第57回日本膵臓学会大会

 The 57th Annual Meeting of the Japan Pancreas Society

７月24日（金）～25日（土）に福岡で開催された第57回日本膵臓学会大会、

上野誠先生が座長をつとめる２日目の ワークショップ「UR-M膵がんに対する集学的治療」、演題『 初診時転移性膵癌におけるConversion Surgeryの治療成績：PC-CURE-1サブ解析』で岡野尚弘先生が発表しました。

At the 57th Annual Meeting of the Japan Pancreas Society in Fukuoka (24–25 July 2026), Dr. Naohiro Okano delivered a presentation. The talk took place on Day 2 during the workshop "Multidisciplinary Treatment for UR-M Pancreatic Cancer," chaired by Dr. Makoto Ueno. Dr. Okano presented on the topic: "Outcomes of Conversion Surgery for Treatment-Naïve Metastatic Pancreatic Cancer: A Subanalysis of PC-CURE-1."

膵癌試験について第126回日本外科学会定期学術集会で発表

[126th JSS] Presenting Our Pancreatic Cancer Study

札幌で開催された第126回日本外科学会定期学術集会会期中の4月25日、PC-CURE-1試験の共同研究者・高橋秀典先生が、「Impact of Induction FOLFIRINOX versus Gemcitabine with Nab-Paclitaxel on Early Recurrence and Post-Recurrence Survival after Conversion Surgery for Unresectable Pancreatic Cancer.」を発表。

On April 25, during the 126th Annual Congress of the Japan Surgical Society held in Sapporo, Prof. Hidenori Takahashi, a co-investigator of the PC-CURE-1 study, presented a talk titled:

“Impact of Induction FOLFIRINOX versus Gemcitabine with Nab-Paclitaxel on Early Recurrence and Post-Recurrence Survival after Conversion Surgery for Unresectable Pancreatic Cancer.”